Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study, Arch Neurol, vol.60, pp.387-392, 2003. ,
MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI ,
, Mov Disord, vol.26, pp.1814-1824, 2011.
Cognitive decline in Parkinson disease, Nat Rev Neurol, vol.13, pp.217-231, 2017. ,
Parkinson's disease dementia: a neural networks perspective, Brain, vol.138, pp.1454-1476, 2015. ,
Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis, Neurodegener Dis, vol.11, pp.79-92, 2013. ,
Visuospatial memory deficits at different stages of Parkinson's disease, Neuropsychologia, vol.31, pp.627-644, 1993. ,
Contrasting mechanisms of impaired attentional setshifting in patients with frontal lobe damage or Parkinson's disease, Brain, vol.116, pp.1159-1175, 1993. ,
Imaging insights into basal ganglia function, Parkinson's disease, and dystonia, Lancet, vol.384, pp.532-544, 2014. ,
Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process, Brain, vol.137, pp.2356-2367, 2014. ,
Grey matter changes in cognitively impaired Parkinson's disease patients, PLoS One, vol.9, p.85595, 2014. ,
Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression, Brain, vol.140, pp.1959-1976, 2017. ,
Parkinson disease: Defining PD subtypes-a step toward personalized management?, Nat Rev Neurol, vol.13, pp.454-455, 2017. ,
Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease, J Comp Neurol, vol.521, pp.4124-4144, 2013. ,
MR analysis of the substantia innominata in normal aging, Alzheimer disease, and other types of dementia, Am J Neuroradiol, vol.23, pp.27-32, 2002. ,
Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study, J Alzheimers Dis, vol.40, pp.687-700, 2014. ,
Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol Aging, vol.24, pp.197-211, 2003. ,
Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease, Brain, vol.137, pp.2493-2508, 2014. ,
Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects, JAMA Neurol, vol.72, pp.194-200, 2015. ,
Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study, Arch Neurol, vol.60, pp.1745-1748, 2003. ,
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo, Neurology, vol.74, pp.885-892, 2010. ,
Heterogeneity of cholinergic denervation in Parkinson's disease without dementia, J Cereb Blood Flow Metab, vol.32, pp.1609-1617, 2012. ,
Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status, Neurobiol Aging, vol.33, pp.1265-1272, 2012. ,
Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease, J Neurol Neurosurg Psychiatry, vol.85, pp.7-16, 2014. ,
Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease, Brain, vol.141, pp.1501-1516, 2018. ,
In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease, Brain, vol.141, pp.165-176, 2018. ,
Cholinergic-dependent cognitive deficits in Parkinson's disease, Ann Neurol, vol.22, pp.26-30, 1987. ,
DOI : 10.1002/ana.410220108
A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease, Brain, vol.111, pp.695-718, 1988. ,
L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction, Psychopharmacology (Berl), vol.107, pp.394-404, 1992. ,
Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia, J Neurol, vol.253, pp.242-247, 2006. ,
Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients, Brain, vol.115, pp.1701-1725, 1992. ,
Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases, J Neurol Neurosurg Psychiatry, vol.55, pp.181-184, 1992. ,
Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease, J Comp Neurol, vol.330, pp.15-31, 1993. ,
Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system, Neuroimage, vol.9, pp.195-207, 1999. ,
DOI : 10.1006/nimg.1998.0396
DPARSF: a MATLAB toolbox for "pipeline" data analysis of resting-state fMRI, Front Syst Neurosci, vol.4, p.13, 2010. ,
REST: a toolkit for restingstate functional magnetic resonance imaging data processing, PLoS One, vol.6, p.25031, 2011. ,
DOI : 10.1371/journal.pone.0025031
URL : https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0025031&type=printable
Methods to detect, characterize, and remove motion artifact in resting state fMRI, Neuroimage, vol.84, pp.320-341, 2014. ,
Frequencies contributing to functional connectivity in the cerebral cortex in "restingstate" data, Am J Neuroradiol, vol.22, pp.1326-1333, 2001. ,
Controlling the false discovery rate: a practical and powerful approach to multiple testing, J R Stat Soc Ser B Methodol, vol.57, pp.289-300, 1995. ,
DOI : 10.1111/j.2517-6161.1995.tb02031.x
Nonparametric permutation tests for functional neuroimaging: a primer with examples, Hum Brain Mapp, vol.15, pp.1-25, 2002. ,
DOI : 10.1002/hbm.1058
URL : https://deepblue.lib.umich.edu/bitstream/2027.42/35194/1/1058_ftp.pdf
A subcortico-cortical cholinergic system is affected in Parkinson's disease, Brain Res, vol.288, pp.213-218, 1983. ,
Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease, Ann Neurol, vol.15, pp.415-418, 1984. ,
Segregation of the human basal forebrain using resting state functional MRI, Neuroimage, vol.173, pp.287-297, 2018. ,
Resting state functional connectivity of the basal nucleus of Meynert in humans: in comparison to the ventral striatum and the effects of age, Neuroimage, vol.97, pp.321-332, 2014. ,
Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey, J Comp Neurol, vol.214, pp.170-197, 1983. ,
Intrinsic functional architecture in the anaesthetized monkey brain, Nature, vol.447, pp.83-86, 2007. ,
The cholinergic contribution to the resting-state functional network in non-demented Parkinson's disease, Sci Rep, vol.8, p.7683, 2018. ,
Manuscript Preparation: A. Writing of the first draft, B. Review and Critique, C. Review and Critique, vol.2 ,
received grants from French Health Ministry (Programme Hospitalier de Recherche Clinique, 2010. ,
UTB Foundation, and Lejeune Foundation. M.V. received unrestricted support for research on Parkinson's disease from Mr Jean-Jacques Legrand (Société Francaise d'Esthétique). S.L. received grants support from Biogen and Fondation Bettencourt Schueller, Recherche Servier, 2013. ,